Ilan Ganot

CIK: 0001727460

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)8 (32.0%)

Position reduction

Option Exercises (M)9 (36.0%)

Derivative conversions

Awards (A)8 (32.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SLDB

Solid Biosciences Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (25 total)

SLDB
Solid Biosciences Inc.
Oct 1, 2026
Award(A)
Restricted Stock Units
Indirect
150K shares-
SLDB
Solid Biosciences Inc.
Jun 10, 2026
Award(A)
Director Stock Option (Right to Buy)
Direct
77.5K shares-
SLDB
Solid Biosciences Inc.
Feb 18, 2026
Sale(S)
Indirect
2.7K shares at avg. $5.82$15K
SLDB
Solid Biosciences Inc.
Feb 13, 2026
Exercise(M)
Indirect
4.9K shares-
SLDB
Solid Biosciences Inc.
Feb 4, 2026
Sale(S)
Indirect
7.2K shares at avg. $6.44$46K
SLDB
Solid Biosciences Inc.
Jan 31, 2026
Exercise(M)
Indirect
15K shares-
SLDB
Solid Biosciences Inc.
Jan 29, 2026
Award(A)
Restricted Stock Units
Indirect
35.5K shares-
SLDB
Solid Biosciences Inc.
Jan 29, 2026
Award(A)
Employee Stock Option (Right to Buy)
Indirect
70.9K shares-
SLDB
Solid Biosciences Inc.
Jan 28, 2026
Sale(S)
Indirect
191 shares at avg. $6.59$1K
SLDB
Solid Biosciences Inc.
Jan 27, 2026
Exercise(M)
Direct
3.9K shares-
SLDB
Solid Biosciences Inc.
Jan 27, 2026
Exercise(M)
Indirect
389 shares-
SLDB
Solid Biosciences Inc.
Jan 5, 2026
Sale(S)
Indirect
1.1K shares at avg. $5.43$6K
SLDB
Solid Biosciences Inc.
Jan 3, 2026
Exercise(M)
Indirect
3K shares-
SLDB
Solid Biosciences Inc.
Nov 10, 2025
Sale(S)
Direct
3.3K shares at avg. $4.12$14K
SLDB
Solid Biosciences Inc.
Aug 14, 2025
Award(A)
Employee Stock Option (Right to Buy)
Indirect
37.5K shares-
SLDB
Solid Biosciences Inc.
Aug 14, 2025
Award(A)
Restricted Stock Units
Indirect
18.8K shares-
SLDB
Solid Biosciences Inc.
Jun 12, 2025
Award(A)
Director Stock Option (Right to Buy)
Direct
77.5K shares-
SLDB
Solid Biosciences Inc.
Feb 14, 2025
Sale(S)
Indirect
1.7K shares at avg. $3.96$7K
SLDB
Solid Biosciences Inc.
Feb 13, 2025
Exercise(M)
Indirect
4.9K shares-
SLDB
Solid Biosciences Inc.
Jan 31, 2025
Award(A)
Restricted Stock Units
Indirect
60K shares-
SLDB
Solid Biosciences Inc.
Jan 28, 2025
Sale(S)
Indirect
144 shares at avg. $3.11$447.782
SLDB
Solid Biosciences Inc.
Jan 27, 2025
Exercise(M)
Direct
3.9K shares-
SLDB
Solid Biosciences Inc.
Jan 27, 2025
Exercise(M)
Indirect
388 shares-
SLDB
Solid Biosciences Inc.
Jan 6, 2025
Sale(S)
Indirect
1.1K shares at avg. $4.31$5K
SLDB
Solid Biosciences Inc.
Jan 3, 2025
Exercise(M)
Indirect
3K shares-

		Type	Shares	Price		Ownership
Oct 1, 2026	SLDB Solid Biosciences Inc.	Award(A) Restricted Stock Units	150,000	-	-	Indirect
Jun 10, 2026	SLDB Solid Biosciences Inc.	Award(A) Director Stock Option (Right to Buy)	77,500	-	-	Direct
Feb 18, 2026	SLDB Solid Biosciences Inc.	Sale(S)	2,658	$5.82	$15,478	Indirect
Feb 13, 2026	SLDB Solid Biosciences Inc.	Exercise(M)	4,861	-	$0	Indirect
Feb 4, 2026	SLDB Solid Biosciences Inc.	Sale(S)	7,205	$6.44	$46,414	Indirect
Jan 31, 2026	SLDB Solid Biosciences Inc.	Exercise(M)	15,000	-	$0	Indirect
Jan 29, 2026	SLDB Solid Biosciences Inc.	Award(A) Restricted Stock Units	35,450	-	-	Indirect
Jan 29, 2026	SLDB Solid Biosciences Inc.	Award(A) Employee Stock Option (Right to Buy)	70,900	-	-	Indirect
Jan 28, 2026	SLDB Solid Biosciences Inc.	Sale(S)	191	$6.59	$1,259	Indirect
Jan 27, 2026	SLDB Solid Biosciences Inc.	Exercise(M)	3,884	-	$0	Direct
Jan 27, 2026	SLDB Solid Biosciences Inc.	Exercise(M)	389	-	$0	Indirect
Jan 5, 2026	SLDB Solid Biosciences Inc.	Sale(S)	1,053	$5.43	$5,718	Indirect
Jan 3, 2026	SLDB Solid Biosciences Inc.	Exercise(M)	2,994	-	$0	Indirect
Nov 10, 2025	SLDB Solid Biosciences Inc.	Sale(S)	3,278	$4.12	$13,505	Direct
Aug 14, 2025	SLDB Solid Biosciences Inc.	Award(A) Employee Stock Option (Right to Buy)	37,500	-	-	Indirect
Aug 14, 2025	SLDB Solid Biosciences Inc.	Award(A) Restricted Stock Units	18,750	-	-	Indirect
Jun 12, 2025	SLDB Solid Biosciences Inc.	Award(A) Director Stock Option (Right to Buy)	77,500	-	-	Direct
Feb 14, 2025	SLDB Solid Biosciences Inc.	Sale(S)	1,711	$3.96	$6,776	Indirect
Feb 13, 2025	SLDB Solid Biosciences Inc.	Exercise(M)	4,861	-	-	Indirect
Jan 31, 2025	SLDB Solid Biosciences Inc.	Award(A) Restricted Stock Units	60,000	-	-	Indirect
Jan 28, 2025	SLDB Solid Biosciences Inc.	Sale(S)	144	$3.11	$448	Indirect
Jan 27, 2025	SLDB Solid Biosciences Inc.	Exercise(M)	3,883	-	$0	Direct
Jan 27, 2025	SLDB Solid Biosciences Inc.	Exercise(M)	388	-	$0	Indirect
Jan 6, 2025	SLDB Solid Biosciences Inc.	Sale(S)	1,056	$4.31	$4,551	Indirect
Jan 3, 2025	SLDB Solid Biosciences Inc.	Exercise(M)	2,994	-	$0	Indirect

1-25 of 25 transactions

About Ganot Ilan

Ganot Ilan (SEC CIK 0001727460) files insider reports with the SEC as Director of Solid Biosciences Inc. (SLDB).

Signal8 holds 14 ownership filings by Ganot Ilan, all Form 4s, filed between Jan 7, 2025 and Oct 26, 2026. Those filings report 25 transactions, from Jan 3, 2025 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Ganot Ilan's filings is in CHARLESTOWN, MA.

Recent filings by Ganot Ilan

Oct 1, 2026: Grant or award of SLDB derivative securities (Form 4, code A).
Jun 10, 2026: Grant or award of SLDB derivative securities (Form 4, code A).
Feb 18, 2026: Open-market sale of SLDB shares (Form 4, code S).
Feb 13, 2026: Option exercise of SLDB shares (Form 4, code M).
Feb 4, 2026: Open-market sale of SLDB shares (Form 4, code S).

Other insiders filing for Solid Biosciences Inc. (SLDB)

Brooks Gabriel, Chief Medical Officer
SMITH IAN F, Director
RA CAPITAL MANAGEMENT, L.P., 10% Owner
Nagendran Sukumar, Director
PERCEPTIVE ADVISORS LLC, Director
Keresty Georgia, Director

How to read Form 4 transaction codes